Raffles Medical Group (SGX:BSL) Tariff Resilience Score: 0/10 (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:BSL Raffles Medical Group Ltd SGX:BSL
54 GF Score
Price S$0.88
GF Value S$0.98
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Raffles Medical Group Tariff Resilience Score?

Raffles Medical Group has the Tariff Resilience Score of 0, which implies that the company might have .

Raffles Medical Group has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Raffles Medical Group might have .

Raffles Medical Group  (SGX:BSL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Raffles Medical Group Tariff Resilience Score Related Terms

SGX:BSL
54GF Score
Raffles Medical Group Ltd SGX:BSL
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Raffles Medical Group (SGX:BSL) Overvalued in 2026?

Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued. The current stock price of S$0.88 is trading 10.2% below its estimated GF Value™ of S$0.98. GuruFocus considers Raffles Medical Group to be Modestly Undervalued.

Key valuation signals for SGX:BSL:

  • Tariff Resilience Score: 0
  • GF Value™: S$0.98 vs. price of S$0.88 (10.2% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the SGX:BSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raffles Medical Group Business Description

Other Exchanges RAFLF:USA
Address 585 North Bridge Road, No. 11-00, Raffles Hospital, Singapore, SGP, 188770
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
54GF Score

Get the complete analysis for SGX:BSL

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.88
Price
S$0.98
GF Value